Skip to content

Improvement of functional constipation by Xylooligosaccharide via modulating gut microbiome

Improvement of functional constipation by Xylooligosaccharide via modulating gut microbiome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015888
Enrollment
Unknown
Registered
2018-04-26
Start date
2018-05-02
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation

Interventions

Low dosage of Xylooligosaccharide:Low dosage of Xylooligosaccharide
Medium dosage of Xylooligosaccharide:Medium dosage of Xylooligosaccharide
High dosage of Xylooligosaccharide:High dosage of Xylooligosaccharide
low dosage of Fructooligosaccharide:low dosage of Fructooligosaccharide
High dosage of Fructooligosaccharide:High dosage of Fructooligosaccharide

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years old; 2. Rome ? standards of the functional constipation developed and officially released by American Gastroenterological Association (AGA) in 2016 will be used: (1) meeting the following two or more standards: 1) defecation difficulties (at least once every 4 defecations); 2) whose stools are block-shaped or hard (at least once every 4 defecations); 3) has defecating unfinished feeling (at least once every 4 defecations); 4) has anorectal obstruction or obstruction feeling (at least once every 4 defecations); 5) needs artificial assistance (at least once every 4 defecations); 6) <3 defecations per week; (2) Almost no loose stools without the usage of laxatives; (3) diagnosis of irritable bowel syndrome without adequate proofs.*Before diagnosis, symptoms appeared at least 6 months ago, and the above diagnostic criteria were met for 3 months.

Exclusion criteria

Exclusion criteria: 1. Abdominal and/or intestinal surgery, appendectomy, cholecystectomy; 2. Rectal prolapse and/or grade 3-4 internal hemorrhoids diagnosed according to AGA diagnostic criteria; 3. Using drugs that affect the intestinal motility, such as: calcium antagonists, nitrates, anti-muscarinic drugs; 4. Take high-dose stimulant laxatives in the past 5 years (three times a week) 5. Is diagnosed IBS or Functional Abdominal Pain Syndrome according to Rome IV; 6. Is identified as grade 5 and above abdominal pain according to the visual analogue scale; 7. Suffering from intestinal obstruction.

Design outcomes

Primary

MeasureTime frame
constipation scoring system, CSS/cleveland clinic score, CCS;patient assessment of constipation quality of life questionnaire, PAC-QOL;Bristol stool form scale, BSFS;The Healthy Lifestyle and Personal Control Questionnaire, HLPCQ;16S sequencing of gut microbiota;

Countries

China

Contacts

Public ContactZhang Feng

Affiliated Hospital of Jiangnan University

zf9958@163.com+86 15301516836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026